Penicillamine for treatment of rheumatoid arthritis.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D003300:Copper / Q000008:administration & dosage; D004341:Drug Evaluation; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D010396:Penicillamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011507:Proteinuria / Q000139:chemically induced; D012217:Rheumatoid Factor / Q000032:analysis; D012877:Skin Manifestations; D013651:Taste Disorders / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D003300:Copper; D012217:Rheumatoid Factor; D010396:Penicillamine